CVR: 43071076
DKK 1,313,877
Gross profit
Net result: DKK 52,751
Novocure GmbH
CVR · view ownership and management
Director registered: Marco Adriano Carrino
CVR · 25/02/2026
View the full event history
Novocure Denmark ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marco Adriano Carrino. The company is owned by Novocure GmbH. In 2025, the company reported a gross profit of DKK 1,313,877 and a net result of DKK 52,751 compared with DKK 833,715 the year before. Equity in the 2025 report amounted to DKK 1,465,999.
Source: annual report 2025, Danish Business Authority
The financial health of Novocure Denmark ApS appears to be improving, with a notable increase in gross profit from 1.89 million DKK in 2022 to 9.96 million DKK in 2024. Profitability has also shown a positive trend, rising from 106,272 DKK in 2022 to 833,715 DKK in 2024. The company's equity has strengthened significantly, reaching 1.47 million DKK by 2025, indicating a solid foundation for future growth. However, the lack of disclosed revenue figures raises concerns about transparency and market position within the pharmaceutical manufacturing industry. Overall, Novocure is on a promising trajectory, but further clarity on revenue generation would enhance its financial profile.
AI-generated summary · Generated 15/08/2026
Selskabets formål er markedsudvikling af medicinsk udstyr til behandling af kræfttumorer og import af medicinsk udstyr samt anden dertil knyttet virksomhed efter bestyrelsens nærmere bestemmelse.
Source: annual reports filed with the Danish Business Authority.
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNovocure Denmark ApS was founded on 15 February 2022.
Novocure Denmark ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Novocure Denmark ApS is owned by Novocure GmbH.
In 2025, Novocure Denmark ApS reported a gross profit of DKK 1,313,877.
The management of Novocure Denmark ApS consists of Marco Adriano Carrino.
Novocure Denmark ApS is located at c/o Tange Gruppen ApS, Skanderborgvej 213 1., 8260 Viby J.
Claim this page to add your logo and social links. Free to get started.
Novocure Denmark ApS has published its annual report for 2025. Gross profit came to DKK 1,313,877, and the net result was DKK 52,751.
As of February 25, 2026, Marco Adriano Carrino is registered as director of Novocure Denmark ApS.
As of November 30, 2025, Ashley Carpenter Cordova has stepped down as director of Novocure Denmark ApS.
Novocure Denmark ApS has published its annual report for 2024. Gross profit came to DKK 9,956,127, and the net result was DKK 833,715.
Novocure Denmark ApS has published its annual report for 2023. Gross profit came to DKK 8,274,042, and the net result was DKK 433,261.
Novocure Denmark ApS has published its interim report for the period February 15, 2022 – December 31, 2022.
As of February 15, 2022, Ashley Carpenter Cordova is registered as director of Novocure Denmark ApS.
As of February 15, 2022, is registered as an owner of Novocure Denmark ApS with an ownership share of 100%.
Novocure Denmark ApS was founded on February 15, 2022.
Companies in the same industry and area
